secwatch.observer — SEC 8-K summary
======================================

Issuer:     Encompass Health Corp (EHC)
CIK:        0000785161
Form:       8-K
Filed at:   2023-09-27T23:59:59+00:00
Accession:  0000785161-23-000058
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Encompass Health reaffirms 5-year growth targets; RCD affirmation >95% in Alabama
--------------------------------------------------------------------------------

- Five-year targets (2023-27): 6-10 de novos/year, 80-120 bed additions/year, 6-8% discharge CAGR.
- Q3 volume trends positive; RCD in Alabama: ~440 records submitted, >95% affirmation rate vs 80% target.
- H1 2023 adjusted EBITDA $478.6M; adjusted EPS from continuing ops $1.83 (diluted).
- 2023 interest expense estimate $145-155M; amortization approx $10M.
- Non-GAAP measures reconciled; company reiterates focus on organic growth and regulatory initiatives.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/785161/000078516123000058/0000785161-23-000058-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/785161/000078516123000058/ehc-20230927.htm
  HTML page:      https://secwatch.observer/filing/0000785161-23-000058

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer